| Data indicate that LASP1 may have an oncogenic function and that it might be regulated by miR-1, miR-133a, and miR-218, which may function as tumor suppressive miRNAs in bladder cancer (BC). | bladder, |
| miR-128 functions as a tumor suppressor by directly targeting ZEB1 in prostate cancer. | prostate, |
| Results showd that miR-128 was negatively associated with IRS1 in colorectal carcinoma (CRC) tissues and suggested that miR-128 serves as a tumor suppressor and blocks CRC growth and metastasis by targeting IRS1. | colorectal, |
| miR128-1 could function as a tumor suppressor in glioblastoma multiforme by negatively regulating tumor cell proliferation, invasion and self-renewal through direct targeting BMI1 and E2F3. | glioblastoma, |
| Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer | esophageal, |
| Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer | thyroid, |
| Knockdown of HOXB8 abolished the effects of miR-128 inhibitor on ovarian cancer cell proliferation and paclitaxel sensitivity. Summarily, miR-128 displayed a tumour suppressor role in ovarian cancer via targeting HOXB8. | ovarian, |
| MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function. | None |